Evidence map›Paper›PMID 42828072›Full record

ArticleContemporary clinical trials communications2026

Creation of a quality assurance and Regulatory Specialist role: A pilot study.

Elizabeth E Robison, Devon M Estes, Jaskaran S Halait, Katelyn L Trigg

Abstract read
In one paragraph

Article in Contemporary clinical trials communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elizabeth E RobisonUniversity of California, Davis, Medical Center, Infectious Diseases Research Unit, United States.
Devon M EstesUniversity of California, Davis, Medical Center, Infectious Diseases Research Unit, United States.
Jaskaran S HalaitUniversity of California, Davis, Medical Center, Infectious Diseases Research Unit, United States.
Katelyn L TriggUniversity of California, Davis, Medical Center, Infectious Diseases Research Unit, United States.

Funding

UC Davis Clinical and Translational Science CenterUL1TR001860 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KENYON, NICHOLAS J., LYLES, COURTNEY REES · 2016 to 2025
$47.3M
NCATS NIH HHS UL1 TR001860
6 · The paper itself

Abstract

Quality assurance activities and research compliance activities are paramount to a healthy and successful research program to ensure participant safety and data integrity are upheld. The UC Davis Infectious Diseases Research Unit (IDRU) supports both interventional and observational research, and about half our portfolio consist of studies that are observational. This article will discuss our experience in creating a unique Quality Assurance and Regulatory Specialist role and how it impacted the quality of research in our unit.

Identifiers

PMID42828072
PMCPMC13631523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.